Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 11 items for :

  • "menopausal hormone therapy" x
Clear All
Panagiotis Anagnostis Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

Search for other papers by Panagiotis Anagnostis in
Google Scholar
PubMed Close
,
Irene Lambrinoudaki 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Medical School, Athens, Greece

Search for other papers by Irene Lambrinoudaki in
Google Scholar
PubMed Close
,
John C Stevenson National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield Hospitals, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

Search for other papers by John C Stevenson in
Google Scholar
PubMed Close
, and
Dimitrios G Goulis Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

Search for other papers by Dimitrios G Goulis in
Google Scholar
PubMed Close

effect of menopausal hormone therapy (MHT) on this risk is also discussed. Does transition to menopause predispose to higher CVD risk? Menopause, defined as the completion of 12 months since the final menstrual period (FMP) or at the time of

Article Type:
Review Article
Collections:
Reproduction
DOI:
https://doi.org/10.1530/EC-21-0537
Volume/Issue:
Volume 11: Issue 4
Open access
Lauren R Cirrincione Department of Pharmacy, University of Washington, Seattle, Washington, USA

Search for other papers by Lauren R Cirrincione in
Google Scholar
PubMed Close
,
Bridgit O Crews Department of Pathology and Laboratory Medicine, University of California Irvine, Orange, California, USA

Search for other papers by Bridgit O Crews in
Google Scholar
PubMed Close
,
Jane A Dickerson Department of Laboratories, Seattle Children's Hospital, Seattle, Washington, USA

Search for other papers by Jane A Dickerson in
Google Scholar
PubMed Close
,
Matthew D Krasowski Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA

Search for other papers by Matthew D Krasowski in
Google Scholar
PubMed Close
,
Jessica Rongitsch Internal Medicine, Capitol Hill Medical, Seattle, Washington, USA

Search for other papers by Jessica Rongitsch in
Google Scholar
PubMed Close
,
Katherine L Imborek Department of Family Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA

Search for other papers by Katherine L Imborek in
Google Scholar
PubMed Close
,
Zil Goldstein Department of Medicine, Callen-Lorde Community Health Center, New York, New York, USA
CUNY Graduate School of Public Health and Health Policy, New York, New York, USA

Search for other papers by Zil Goldstein in
Google Scholar
PubMed Close
, and
Dina N Greene Washington Kaiser Permanente, Renton, Washington, USA
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA

Search for other papers by Dina N Greene in
Google Scholar
PubMed Close

estrogen treatment, several investigators examined immunoassay performance among adults taking oral exogenous estradiol treatment for either ovarian stimulation or menopausal hormone therapy ( 17 , 18 ). Dancoine et al. observed agreement between an

Article Type:
Research Article
Collections:
Reproduction
DOI:
https://doi.org/10.1530/EC-21-0550
Volume/Issue:
Volume 11: Issue 2
Open access
Elizabeth Micks Department of Obstetrics and Gynecology, Department of Research, University of Washington, Box 356460, 1959 NE Pacific Street, Seattle, Washington, USA

Search for other papers by Elizabeth Micks in
Google Scholar
PubMed Close
,
Greta B Raglan Department of Obstetrics and Gynecology, Department of Research, University of Washington, Box 356460, 1959 NE Pacific Street, Seattle, Washington, USA

Search for other papers by Greta B Raglan in
Google Scholar
PubMed Close
, and
Jay Schulkin Department of Obstetrics and Gynecology, Department of Research, University of Washington, Box 356460, 1959 NE Pacific Street, Seattle, Washington, USA
Department of Obstetrics and Gynecology, Department of Research, University of Washington, Box 356460, 1959 NE Pacific Street, Seattle, Washington, USA

Search for other papers by Jay Schulkin in
Google Scholar
PubMed Close

CD002229 . ( doi:10.1002/14651858.CD002229.pub4 ). 88 Fournier A Mesrine S Boutron-Ruault MC Clavel-Chapelon F . Estrogen–progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-15-0093
Volume/Issue:
Volume 4: Issue 4
Open access
Yunting Lin Department of Surgical Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China

Search for other papers by Yunting Lin in
Google Scholar
PubMed Close
,
Endi Song Department of Internal Medicine, Ningbo Yinzhou No.2 Hospital, Ningbo, Zhejiang, China

Search for other papers by Endi Song in
Google Scholar
PubMed Close
,
Han Jin Department of Medicine, Ningbo University, Ningbo, Zhejiang, China

Search for other papers by Han Jin in
Google Scholar
PubMed Close
, and
Yong Jin Department of Internal Medicine, Ningbo Yinzhou No.2 Hospital, Ningbo, Zhejiang, China

Search for other papers by Yong Jin in
Google Scholar
PubMed Close

cohort study . BMJ 2014 349 g5992 . ( https://doi.org/10.1136/bmj.g5992 ) 23 Prabakaran S Schwartz A & Lundberg G . Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and

Article Type:
Research Article
Collections:
Obesity
DOI:
https://doi.org/10.1530/EC-24-0190
Volume/Issue:
Volume 13: Issue 9
Open access
Brendan J Nolan Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia

Search for other papers by Brendan J Nolan in
Google Scholar
PubMed Close
,
Aviva S Frydman Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Aviva S Frydman in
Google Scholar
PubMed Close
,
Shalem Y Leemaqz College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia

Search for other papers by Shalem Y Leemaqz in
Google Scholar
PubMed Close
,
Meg Carroll Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia

Search for other papers by Meg Carroll in
Google Scholar
PubMed Close
,
Mathis Grossmann Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia

Search for other papers by Mathis Grossmann in
Google Scholar
PubMed Close
,
Jeffrey D Zajac Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia

Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed Close
, and
Ada S Cheung Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia

Search for other papers by Ada S Cheung in
Google Scholar
PubMed Close

development in a prospective study ( 7 ). There are currently no data with micronised progesterone. Micronised progesterone is often prescribed for endometrial protection with oestradiol as menopausal hormone therapy for cisgender women with an intact uterus

Article Type:
Research Article
Collections:
Reproduction
DOI:
https://doi.org/10.1530/EC-22-0170
Volume/Issue:
Volume 11: Issue 5
Open access
Johanna Christina Penell Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden
Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, Uppsala, Sweden

Search for other papers by Johanna Christina Penell in
Google Scholar
PubMed Close
,
Mark M Kushnir Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA
ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA

Search for other papers by Mark M Kushnir in
Google Scholar
PubMed Close
,
Lars Lind Department of Medical Sciences, Cardiovascular Epidemiology, Uppsala University, Uppsala, Sweden

Search for other papers by Lars Lind in
Google Scholar
PubMed Close
,
Jonatan Bergquist Department of Chemistry – BMC, Analytical Chemistry, Uppsala University, Uppsala, Sweden

Search for other papers by Jonatan Bergquist in
Google Scholar
PubMed Close
,
Jonas Bergquist Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA
Department of Chemistry – BMC, Analytical Chemistry, Uppsala University, Uppsala, Sweden

Search for other papers by Jonas Bergquist in
Google Scholar
PubMed Close
,
P Monica Lind Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, Uppsala, Sweden

Search for other papers by P Monica Lind in
Google Scholar
PubMed Close
, and
Tord Naessen Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden

Search for other papers by Tord Naessen in
Google Scholar
PubMed Close

). All the study participants underwent a physical examination; information on history of coronary heart disease (CHD) and menopausal hormone therapy (MHT) was available, as previously described ( 29 ). Study design CVD was defined as the self

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0045
Volume/Issue:
Volume 10: Issue 5
Open access
Orwa Dandash Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Orwa Dandash in
Google Scholar
PubMed Close
,
James Allebone Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by James Allebone in
Google Scholar
PubMed Close
,
Adam Mirabelli Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Adam Mirabelli in
Google Scholar
PubMed Close
,
Nicholas Russell Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Nicholas Russell in
Google Scholar
PubMed Close
,
Mathis Grossmann Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Mathis Grossmann in
Google Scholar
PubMed Close
,
Andrea Gogos Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia
Department of Florey Institute, University of Melbourne, Parkville, Victoria, Australia

Search for other papers by Andrea Gogos in
Google Scholar
PubMed Close
, and
Richard A Kanaan Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Richard A Kanaan in
Google Scholar
PubMed Close

( 28 ), and in postmenopausal women on combined menopausal hormone therapy who performed better on visuospatial and working memory tasks compared to controls ( 29 , 30 ). Together these findings indicate that ADT may have suppressive effects on

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-23-0409
Volume/Issue:
Volume 13: Issue 3
Open access
Trevor Lewis Physiotherapy Department, Aintree University Hospital NHS Foundation Trust, Liverpool, UK

Search for other papers by Trevor Lewis in
Google Scholar
PubMed Close
,
Eva Zeisig Department of Surgical and Perioperative Sciences, Umeå Univerisity, Umeå, Sweden

Search for other papers by Eva Zeisig in
Google Scholar
PubMed Close
, and
Jamie E Gaida University of Canberra Research Institute for Sport and Exercise (UCRISE), Canberra, Australian Capital Territory, Australia

Search for other papers by Jamie E Gaida in
Google Scholar
PubMed Close

. Does menopausal hormone therapy (MHT), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)? A randomised controlled trial . BMC Women’s Health 2016 16 32 . ( https

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-19-0555
Volume/Issue:
Volume 9: Issue 3
Open access
Herjan J T Coelingh Bennink Pantarhei Oncology, Zeist, The Netherlands

Search for other papers by Herjan J T Coelingh Bennink in
Google Scholar
PubMed Close
,
Jan Krijgh Pantarhei Oncology, Zeist, The Netherlands

Search for other papers by Jan Krijgh in
Google Scholar
PubMed Close
,
Jan F M Egberts Terminal 4 Communications, Hilversum, The Netherlands

Search for other papers by Jan F M Egberts in
Google Scholar
PubMed Close
,
Maria Slootweg Independent Consultant, Zeist, The Netherlands

Search for other papers by Maria Slootweg in
Google Scholar
PubMed Close
,
Harm H E van Melick Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands

Search for other papers by Harm H E van Melick in
Google Scholar
PubMed Close
,
Erik P M Roos Department of Urology, Antonius Hospital, Sneek, The Netherlands

Search for other papers by Erik P M Roos in
Google Scholar
PubMed Close
,
Diederik M Somford Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands

Search for other papers by Diederik M Somford in
Google Scholar
PubMed Close
,
Yvette Zimmerman Pantarhei Oncology, Zeist, The Netherlands

Search for other papers by Yvette Zimmerman in
Google Scholar
PubMed Close
,
Iman J Schultz Pantarhei Oncology, Zeist, The Netherlands

Search for other papers by Iman J Schultz in
Google Scholar
PubMed Close
,
Noel W Clarke The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK

Search for other papers by Noel W Clarke in
Google Scholar
PubMed Close
,
R Jeroen A van Moorselaar Department of Urology, Amsterdam UMC, VU University, Amsterdam, The Netherlands

Search for other papers by R Jeroen A van Moorselaar in
Google Scholar
PubMed Close
, and
Frans M J Debruyne Andros Clinics, Arnhem, The Netherlands

Search for other papers by Frans M J Debruyne in
Google Scholar
PubMed Close

at a high dose level of 40 mg E4 (HDE4) per day ( 25 ), which is more than double the 15 mg daily dose developed for hormonal oral contraception and menopausal hormone therapy ( 63 , 64 , 65 ). Major differences between both methods are that tE2 is

Article Type:
Review Article
Collections:
Bone and Mineral Metabolism
DOI:
https://doi.org/10.1530/EC-22-0182
Volume/Issue:
Volume 11: Issue 12
Open access
Nancy Martini Laboratorio de Investigaciones en Osteopatías y Metabolismo Mineral (LIOMM-UNLP-CICPBA), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina

Search for other papers by Nancy Martini in
Google Scholar
PubMed Close
,
Lucas Streckwall Laboratorio de Investigaciones en Osteopatías y Metabolismo Mineral (LIOMM-UNLP-CICPBA), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina

Search for other papers by Lucas Streckwall in
Google Scholar
PubMed Close
, and
Antonio Desmond McCarthy Laboratorio de Investigaciones en Osteopatías y Metabolismo Mineral (LIOMM-UNLP-CICPBA), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina

Search for other papers by Antonio Desmond McCarthy in
Google Scholar
PubMed Close

menopausal females . Medical Research Archives 2018 6 1663 . 49 Gosset A Pouillès JM & Trémollieres F . Menopausal hormone therapy for the management of osteoporosis . Best Practice and Research. Clinical Endocrinology and Metabolism 2021 35

Article Type:
Review Article
Collections:
Bone and Mineral Metabolism
DOI:
https://doi.org/10.1530/EC-23-0305
Volume/Issue:
Volume 12: Issue 11
Open access